J0890 — Injection, peginesatide, 0.1 mg (for esrd on dialysis)
J0890 is a HCPCS Level II code for injection, peginesatide, 0.1 mg (for esrd on dialysis). It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
Medically Unlikely Edits — units per day
The most units of J0890 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.
- practitioner
- 0 — never payable MAI 3 — Date of Service Edit: Clinical · Drug discontinued
- outpatient
- 0 — never payable MAI 3 — Date of Service Edit: Clinical · Drug discontinued
- DME supplier
- 0 — never payable MAI 3 — Date of Service Edit: Clinical · Drug discontinued
The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.
The CMS record for J0890
- Long descriptor
- Injection, peginesatide, 0.1 mg (for esrd on dialysis)
- Short descriptor
- Peginesatide injection
- Added
- January 1, 2013
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0890
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0890 is not quite right, the correct code is very often within a few positions of it.
- J0882Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)
- J0883Injection, argatroban, 1 mg (for non-esrd use)
- J0884Injection, argatroban, 1 mg (for esrd on dialysis)
- J0885Injection, epoetin alfa, (for non-esrd use), 1000 units
- J0886Injection, epoetin alfa, 1000 units (for esrd on dialysis)terminated
- J0887Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- J0888Injection, epoetin beta, 1 microgram, (for non esrd use)
- J0889Daprodustat, oral, 1 mg, (for esrd on dialysis)terminated
- J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
- J0894Injection, decitabine, 1 mg
- J0895Injection, deferoxamine mesylate, 500 mg
- J0896Injection, luspatercept-aamt, 0.25 mg
- J0897Injection, denosumab, 1 mg
- J0898Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
Questions about J0890
What is HCPCS code J0890?
J0890 is a HCPCS Level II code for injection, peginesatide, 0.1 mg (for esrd on dialysis). It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0890?
The CMS HCPCS file marks J0890 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J0890 paid under the physician fee schedule?
J0890 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).